Celcuity Inc (CELC) Q3 2026 Earnings Call Highlights: Revtorpic's Strong Launch Momentum Meets ...
Celcuity Inc (CELC) reports robust early commercial uptake of Revtorpic with 78% of top strategic accounts ordering, while posting a $73.3 million net loss and no product revenue in Q3 2026. Related Stocks: CELC ,